MYRIAD GENETICS INC

MYGN · XNAS

CIK 899923fmd_0MP6QC3QT4ECMZJ6WDRDNAX0EPManufacturing · In Vitro & In Vivo Diagnostic SubstancesTemplate: Standard

Coverage: Jul 01, 2008 to Sep 30, 2026, 70 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.